Lilly 127935

Known as: Ly 127935, Ly-127935, Ly127935 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1981
1981
To measure the susceptibility of penicillin-resistant pneumococci to newer beta-lactam agents, we evaluated 54 selected strains… (More)
Is this relevant?
1980
1980
The practical application of thienamycin, a novel beta-lactam antibiotic with a broad activity spectrum, was compromised by… (More)
Is this relevant?
1980
1980
Minimum inhibitory concentrations and agar disk diffusion tests were determined on clinical isolates of beta-lactamase-positive… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
1980
1980
Moxalactam (LY127935) is a 1-oxa-beta-lactam which was active in vitro against the majority of 128 strains of gram-negative… (More)
Is this relevant?
1980
1980
The in vitro activity of cefoperazone was tested against 155 clinical isolates of anaerobic bacteria and compared to that of… (More)
Is this relevant?
1980
1980
This study compares the minimum inhibitory concentrations of cefoperazone, cefotaxime, and moxalactam (LY127935) for 446 aerobic… (More)
  • table 2
  • figure 2
  • figure 1
Is this relevant?
1980
1980
Moxalactam (LY127935) exhibited greater in vitro activity than cefamandole and tobramycin against clinical isolates of… (More)
Is this relevant?
1979
1979
Pseudomonas maltophilia is resistant to most of the commonly used antimicrobial agents including those active against Pseudomonas… (More)
Is this relevant?
1979
1979
The in vitro activities of LY127935 (LY) were compared with those of other beta-lactam antibiotics. LY was highly active (minimal… (More)
Is this relevant?
1979
1979
The in vitro activity of LY-127935, a new beta-lactam antibiotic, was examined by using 370 clinical bacterial strains. In… (More)
Is this relevant?